Ex parte TODARO et al. - Page 2




              Appeal No. 1997-3020                                                                                           
              Application 08/149,101                                                                                         

                                                 DECISION ON APPEAL                                                          
                      This is an appeal under 35 U.S.C. § 134 from the final rejection of claims                             
              1 through 28.  Subsequently, claims 29 through 33 were added to the application. Claims                        
              29 and 30 are objected to as being dependent upon a rejected base claim.  Claims 31                            
              through 33 are allowed.  Claims 1 and 12 are illustrative of the subject matter on appeal                      
              and read as follows:                                                                                           
                      1.   A hybrid cytokine polypeptide comprising: 1) four "-helical sequences, the                        
              "-helical sequences selected from cytokine "-helical sequences, the cytokine being                             
              selected from the group consisting of leukemia inhibitory factor (L), granulocyte colony                       
              stimulating factor (G), interleukin-6(I), interleukin-11(E), ciliary neurotrophic factor (C), and              
              oncostatin-M (O); and 2) three linking sequences, the linking sequences selected from at                       
              least a portion of one or more linking sequences from any of the foregoing cytokines,                          
              wherein at least one of the four "-helical sequences is derived from a different cytokine                      
              than at least one other of the four "-helical sequences.                                                       
                      12.  A DNA molecule that encodes a hybrid cytokine, the hybrid cytokine                                
              comprising: 1) four "-helical sequences selected from an "-helical sequence derived from                       
              a cytokine, the cytokine being selected from the group consisting of L, G, I, E, C and O;                      
              and 2) three linking sequences selected from at least a portion of a linking sequence from                     
              any of the foregoing cytokines, wherein at least one of the four "-helical sequences is from                   
              a different cytokine than at least one other of the four "-helical sequences, said DNA                         
              molecule comprising:                                                                                           
                      (A) complementary strands;                                                                             
                      (B) DNA molecules which hybridize, under conditions of high stringency, to a probe                     
              consisting of any of the foregoing DNA molecules or their complementary sequences; and                         
                      (C) DNA molecules which would hybridize to the DNA molecules set forth above or                        
              a probe derived from a DNA molecule encoding any of the foregoing hybrid cytokines, but                        
              for a degeneracy of genetic code.                                                                              



                                                             2                                                               





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  Next 

Last modified: November 3, 2007